Twin TrueBeam Device

Twin TrueBeam Device

Warith International Cancer Institute (WICI) is distinguished by providing the latest equipment for treating cancer patients, such as the Twin TrueBeam device. The Varian TrueBeam radiation therapy system represents a significant advancement in radiation therapy, allowing doctors to target hard-to-reach tumors with great precision while minimizing impact on surrounding healthy tissues. The Warith International Cancer Institute is pleased to offer this innovative treatment alongside other advanced, world-class cancer therapies for patients.
The TrueBeam device delivers the prescribed radiation dose from almost any angle. It integrates imaging and dose delivery with technology designed to revolve around patients, allowing for precise and rapid targeting of tumors. Real-time imaging tools allow doctors to see the growth they are treating.
Like other forms of radiation therapy, the TrueBeam device delivers a radiation dose that damages cancer cells and prevents them from spreading. After treatment, the tumor stops growing, and in many cases, it disappears over time.

Features of the TrueBeam Device:
1. The TrueBeam devic offers flexible treatment options. It provides a variety of treatment techniques, such as SRS, SBR, IMRT, and VMAT to address a wide range of cancer cases.
2. High-precision dose control ensures the delivery of the required sub-millimeter dose in accurate manner.
3. The TrueBeam device offers integrated safety features for patients, allowing doctors to handle the complexities of cancer patient care with confidence.
4. Doctors use the TrueBeam device to treat lung tumors, brain tumors, bone tumors, and metastatic cancers.
5. The TrueBeam device allows for breath control, with the capability to synchronize the delivery of the therapeutic dose with the patient's breathing. Inhalation and exhalation can slightly move the tumor position, which can affect the effectiveness of the radiation therapy.

Features of the Twin TrueBeam Device:
1. The most notable feature of the Twin TrueBeam Device is the presence of two identical machines, where the radiation emitted from the first device is the same as the radiation from the second device. This is why it is named the "Twin TrueBeam."
2. This dual feature is beneficial in the event of a malfunction or the need for maintenance on one of the machines, as it eliminates the need to change the patient's treatment plan or perform new planning. Instead, treatment can continue on the second machine. This ensures continuity of treatment without interruption, enhancing the effectiveness of the therapy and the patient’s comfort.

Related news

  • Warith localize manufacturing of biological, cellular, and gene therapies in Iraq through 3 U.S. partnerships

    We announce the conclusion of three strategic partnerships with specialized U.S. entities, aimed at localizing the manufacturing technologies for biopharmaceuticals and cell and gene therapies inside Iraq — a step described as a qualitative leap in the development of the national health sector. Dr. Haider Hamza Al-Abidi, Head of the Health and Medical Education Authority at the Holy Imam Hussain Shrine, said the agreements, concluded during his visit to the United States, include the provision of a modern bioreactor and its laboratory supplies in partnership with the global company Thermo Fisher, in addition to a clinical and training partnership with Boston Children's Hospital, the primary teaching affiliate of Harvard University, as well as an agreement with a partner specialized in transferring technologies locally to ensure the integration of the therapeutic system. He affirmed that the project builds on a supportive infrastructure, including bone marrow transplant procedures at Al-Mujtaba Hospital and the international accreditation of the Warith Foundation, noting that these partnerships will contribute to providing advanced treatments inside Iraq at prices lower than their global counterparts, and to ending reliance on sending patients abroad for specialized treatments, particularly children with cancers and complex diseases.

All news